期刊文献+

丙型肝炎病毒CTL表位的HLA-A2限制性及其免疫学效应研究 被引量:3

The HLA-A2 restriction and immunogenicity of hepatitis C virus-specific cytotoxic T lymphocyte epitopes
原文传递
导出
摘要 目的研究前期鉴定的5条丙型肝炎病毒(HCV)特异忡细胞毒性T细胞(CTL)表位的HLA—A2限制性及其免疫学效应。方法基于1、2细胞株,采用MHC-肽复合物稳定性试验研究前期鉴定的HCV特异性CTL表位与HLA—A2分子的亲和力;采用细胞内细胞因子染色(intracellular cytokine staining,ICS)和ELISPOT研究上述HLA—A2限制性CTL表位体外刺激HLA—A2阳性外周血单个核细胞(PBMC)产生肽特异性CTL的效应;采坩CTL杀伤试验研究上述肽特异性CTL杀伤靶细胞(负载相同肽的T2细胞)的效应。结果前期研究鉴定的5条CTL表位肽中,NSdb_78(SMMAF-SAAL)和NS5a_367(TVSSALAEL)与HLA—A2分子有高亲和力(FI〉1);ELISPOT结果显示NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)可诱导高水平的分泌IFN-γ的效应细胞[分别为(60±6)SFC/10^4 PBMCvs(4±1)SFC/10^4 PBMC,P〈0.001:(10±3)SFC/10^4 PBMC vs (2±1)SFC/10^4 PBMC,P〈0.001];ICS结果证实这两条肽刺激HLA—A2阳性PBMC后,在CD8^+T细胞中产生了高百分比的CD8^+ IFN-γ^+ T[分别为(2.33±0.22)%vs(0.05±0.01)%,P〈0.001;(0.36±0.06)%vs(0.03±0.01)%,P〈0.001];并且,肽特异性CTL可特异性杀伤负载相同肽的T2细胞。结论NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)受HLA—A2限制,并具有较好的免疫原性。 Objective To explore the HLA-A2 restriction and immunogenieity of 5 previously identified HCV-specific CTL epitopes. Methods Based on T2 cell,to explore the HLA-A2 restriction of previously identified HCV-specific CTL epitopes by MHC-peptide complex stabilization assay;To detect peptide-specific CTL in HLA-A2 + PBME stimulated by HLA-A2-restricted peptides by intracellular cytokine staining(ICS) and ELISPOT; To explore the eytotoxieity of peptide-specifie CTL to same peptide-loaded T2 cells (target cells) by CTL cytotoxicity test. Results Among 5 previously identified CTL epitopes NS4b_78 (SMMAFSAAL) and NS5a_367 (TVSSALAEL) have high-affinity for HLA-A2 molecules( FI 〉 1 ) ; ELISPOT results shown that NS4b_78 (SMMAFSAAL) and NS5a_367 (TVSSALAEL) induced high levels of IFN-γ-seereting cells [ (60 ± 6) SFC/10^4 PBMC vs (4 ± 1 ) SFC/10^4 PBMC, P 〈 0.01 ; ( 10±3) SFC/10^4 PBMC vs (2± 1 ) SFC/10^4 PBMC, P 〈0.01, respectively] ;ICS results indicated that there were high percentages of CD8 ^+ IFN-γ^+ T cells in total CD8^+ T cells stimulated by these peptides [ ( 2.33 ± 0.22 ) % vs ( 0.05 ± 0.01)%, P〈0.001;(0.36 ±0.06)% vs (0.03±0.01)%, P〈0.001, respectively]. Furthermore, peptide-specific CTL could effectively kill same peptide-loaded T2 cells. Conclusion NS4b_78 ( SMMAF- SAAL) and NS5a_367 (TVSSALAEL) were identified as HLA-A2-restricted CTL epitopes which could induce immune response in vitro.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第9期822-826,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30800050) 温州市科技计划项目(Y20080104) 温州医学院博士启动基金(QTJ07007)
关键词 细胞毒性T细胞 HLA-A2 免疫原性 Cytotoxic T lymphoeytes HLA-A2 Immunogeneeity
  • 相关文献

参考文献10

  • 1Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 2005, 436 (7053): 946 -952.
  • 2段志良,陈永平,孟锐峰,姜爱英,陈俊,郑明华,文金生.丙型肝炎病毒非结构区5个细胞毒性T细胞表位的鉴定[J].中华微生物学和免疫学杂志,2009,29(1):41-45. 被引量:1
  • 3Sreenarasimhaiah J, Jaramillo A, Crippin J, et al. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol, 2003, 64(2) : 224-230.
  • 4Prince AM. Challenges for development of hepatitis C virus vaccines. FEMS Microbiol Rev, 1994, 14(3) : 273-277.
  • 5Grakoui A, Shoukry NH, Woollard DJ, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science, 2003, 302(5645): 659-662.
  • 6Ogasawara K. Synthetic peptide vaccines effective in preventing virus infection. Microbiol Immunol, 1999, 43 (10): 915-923.
  • 7Thimme R, Oldach D, Chang MK, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med, 2001, 194(10) : 1395-1406.
  • 8Hu SP, Luan JA, Li B, et al. Genetic link between chaoshan and other Chinese Han populations: evidence from HLA-A and HLA- B allele frequency distribution. Am J Phys Antbropol, 2007, 132 ( 1 ) : 140-150.
  • 9Elkington R, Walker S, Crough T, et al. Ex vivo profiling of CD8^+ T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol, 2003, 77(9) : 5226-5240.
  • 10Khanna R. Predictive Algorithms and T cell epitope mapping. J Immunol, 2004, 173(5) : 2895.

二级参考文献20

  • 1Lohmann V, Koch JO, Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J Hepatol, 1996, 24(2 Suppl) : 11-19.
  • 2Amoroso P, Rapicetta M, Tosti ME, et al. Correlation between virus genotype and cbronicity rate inacute hepatitis C. J Hepatol, 1998, 28(6) : 939-944.
  • 3Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 2005, 436 (7053) : 946-952.
  • 4Dikopoulos N, Riedl P, Schirmbeck R, et al. Novel peptidebased vaccines efficiently prime murine " help "-independent CD8+ T cell responses in the liver. Hepatology, 2004, 40 (2) : 300-309.
  • 5Kurokohchi K, Arima K, Nishioka M. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection. J Hepatol, 2001,34(6) : 930-935.
  • 6Huy TT, Abe K. Molecular epidemiology of hepatitis B and C virus infections in Asia. Pediatr Int, 2004, 46 (2) : 223-230.
  • 7Wen JS, Jiang LF, Zhou JM, et al. Computational prediction and identification of dengue virus-specific CD4+ T-cell epitopes. Virus Res, 2008, 132(1-2) : 42-48.
  • 8Lasarte JJ, Garcta-Granero M, Lopez A, et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology, 1998, 28 (3) : 815-822.
  • 9Gomez-Nunez M, Pinilla-Ibarz J, Dao T, et al. Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A * 0201 molecules. Leuk Res, 2006, 30(10): 1293-1298.
  • 10Simmons CP, Dong T, Chau NV, et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol, 2005, 79(9) : 5665-5675.

同被引文献39

  • 1Lohmann V,Koch JO,Bartenschlager R.Processing pathways of the hepatitis C virus proteins[J].J Hepatol,1996,24(2 Suppl):11-19.
  • 2Amoroso P,Rapicetta M,Tosti ME,et al.Correlation between virus genotype and chronicity rate in acute hepatitis C[J].J Hepatol,1998,28(6):939-944.
  • 3Bowen DG,Walker CM.Adaptive immune responses in acute and chronic hepatitis C virus infection[J].Nature,2005,436(7053):946-952.
  • 4Torresi J,Bharadwaj M,Jackson DC,et al.Neutralising antibody,CTL and dendritic cell responses to hepatitis C virus:a preventive vaccine strategy[J].Curr Drug Targets,2004,5(1):41-56.
  • 5Hu SP,Luan JA,Li B,et al.Genetic link between Chaoshan and other Chinese Han populations:Evidence From HLA-A and HLA-B allele frequency distribution[J].Am J Phys Anthropol,2007,132(1),140-150.
  • 6Dikopoulos N,Riedl P,Schirmbeck R,et al.Novel peptidebased vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver[J].Hepatology,2004,40(2):300-309.
  • 7Kurokohchi K,Arima K,Nishioka M.A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection[J].J Hepatol,2001,34(6):930-935.
  • 8Reche PA,Glutting JP,Reinherz EL.Prediction of MHC class Ⅰ binding peptides using profile motifs[J].Hum Immunol,2002,63(9):701-709.
  • 9Gomez-Nunez M,Pinilla-Ibarz J,Dao T,et al.Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules[J].Leuk Res,2006,30(10):1293-1298.
  • 10Chang KM,Gruener NH,Southwood S,et al.Identification of HLA-A3 and-B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C[J].J Immunol,1999,162(2):1156-1164.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部